These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32531327)

  • 61. Disposable NPWT device to facilitate early patient discharge following complex DFU.
    Khanbhai M; Fosah R; Oddy MJ; Richards T
    J Wound Care; 2012 Apr; 21(4):180, 182. PubMed ID: 22584676
    [TBL] [Abstract][Full Text] [Related]  

  • 62. miR-23c regulates wound healing by targeting stromal cell-derived factor-1α (SDF-1α/CXCL12) among patients with diabetic foot ulcer.
    Amin KN; Umapathy D; Anandharaj A; Ravichandran J; Sasikumar CS; Chandra SKR; Kesavan R; Kunka Mohanram R
    Microvasc Res; 2020 Jan; 127():103924. PubMed ID: 31520606
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Negative pressure wound therapy: a vacuum of evidence?
    Gregor S; Maegele M; Sauerland S; Krahn JF; Peinemann F; Lange S
    Arch Surg; 2008 Feb; 143(2):189-96. PubMed ID: 18283145
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical outcome of diabetic foot ulcers treated with negative pressure wound therapy and the transition from acute care to home care.
    Wu SC; Armstrong DG
    Int Wound J; 2008 Jun; 5 Suppl 2(Suppl 2):10-6. PubMed ID: 18577133
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Negative pressure wound therapy in patients with diabetic foot.
    Ulusal AE; Sahin MS; Ulusal B; Cakmak G; Tuncay C
    Acta Orthop Traumatol Turc; 2011; 45(4):254-60. PubMed ID: 21908965
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Complex treatment of patients with pyo-necrotic complications of the neuropathic form of diabetic foot syndrome].
    Belik BM; Chumburidze IP; Shtilman MY; Yavruyan OA; Savchenko YP
    Khirurgiia (Mosk); 2020; (4):81-87. PubMed ID: 32352675
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Negative-pressure wound therapy and diabetic foot amputations: a retrospective study of payer claims data.
    Frykberg RG; Williams DV
    J Am Podiatr Med Assoc; 2007; 97(5):351-9. PubMed ID: 17901338
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A histological analysis of chronic wounds treated with negative pressure wound therapy to aid healing: a case series.
    Almeida JE; Suárez R; Gibson E
    J Wound Care; 2018 Feb; 27(Sup2):S28-S34. PubMed ID: 29419368
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Negative-pressure wound therapy induces endothelial progenitor cell mobilization in diabetic patients with foot infection or skin defects.
    Seo SG; Yeo JH; Kim JH; Kim JB; Cho TJ; Lee DY
    Exp Mol Med; 2013 Nov; 45(11):e62. PubMed ID: 24232261
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Decreased expression of miR-24 in peripheral plasma of type 2 diabetes mellitus patients associated with diabetic foot ulcer.
    Li X; Tang Y; Jia Z; Zhao X; Chen M
    Wound Repair Regen; 2020 Nov; 28(6):728-738. PubMed ID: 32710681
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Primary wound closure of diabetic foot ulcers by debridement and stitching.
    Ahmed ME; Mohammed MS; Mahadi SI
    J Wound Care; 2016 Nov; 25(11):650-654. PubMed ID: 27827282
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Negative pressure wound therapy accelerates rats diabetic wound by promoting agenesis.
    Li X; Liu J; Liu Y; Hu X; Dong M; Wang H; Hu D
    Int J Clin Exp Med; 2015; 8(3):3506-13. PubMed ID: 26064242
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Features of angenesis against the background of negative pressure wound therapy in patients with neuropathic and neuroischemic forms of diabetic foot ulcers].
    Zaĭtseva EL; Doronina LP; Molchkov RV; Voronkova IA; Mitish VA; Tokmakova AIu
    Vestn Khir Im I I Grek; 2014; 173(5):64-72. PubMed ID: 25823338
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Human acellular dermal wound matrix for complex diabetic wounds.
    Rupert P
    J Wound Care; 2016 Apr; 25(4):S17-8, S20-1. PubMed ID: 27068343
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A comparison of diabetic foot ulcer outcomes using negative pressure wound therapy versus historical standard of care.
    Lavery LA; Boulton AJ; Niezgoda JA; Sheehan P
    Int Wound J; 2007 Jun; 4(2):103-13. PubMed ID: 17651226
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Semiclosure wound therapy plus negative pressure wound therapy for an older patient with grade 4 diabetic foot with concomitant vascular occlusion: A case report.
    Yan Y; Li W; Song Y; Yin P; He Z; Gong Y; Peng L
    Medicine (Baltimore); 2019 Nov; 98(44):e17786. PubMed ID: 31689851
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Plausible solution to prevent major amputation in diabetic foot patients].
    Laginja S; Seremet J; Spehar B; Marinović M
    Acta Med Croatica; 2014 Oct; 68 Suppl 1():87-9. PubMed ID: 25326996
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of Negative Pressure Wound Therapy on Infectious Complications in Grade III Open Fractures].
    Krtička M; Ira D; Nekuda V; Švancara J; Mašek M
    Acta Chir Orthop Traumatol Cech; 2016; 83(2):117-22. PubMed ID: 27167417
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy.
    Zhang D; Li Z; Wang Z; Zeng F; Xiao W; Yu A
    Diabetes Metab Syndr Obes; 2019; 12():1685-1696. PubMed ID: 31564936
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.